Free Trial

Krystal Biotech (KRYS) Stock Chart & Stock Price History

Krystal Biotech logo
$305.23 -0.45 (-0.15%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$307.50 +2.27 (+0.74%)
As of 11/13/2026 07:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Krystal Biotech Stock Price Performance

The Krystal Biotech (KRYS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 48.05%, with a year-to-date return of 23.81%. In the past month, the stock has decreased 7.51%, reflecting recent market activity.

As of the latest close, Krystal Biotech traded at $305.23 with a market cap of $9.04 billion and volume of 109,686 shares. Five years ago, the stock traded at $47.45, representing a 543.27% increase over that period. At the time, it had a market cap of $1.06 billion and a volume of 165,831 shares.

Receive KRYS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Krystal Biotech and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
5 Day
Performance
-0.41%
1 Month
Performance
-7.51%
3 Month
Performance
-8.14%
Year-To-Date
Performance
+23.81%
1 Year
Performance
+48.05%
5 Year
Performance
+543.27%

KRYS Stock Chart for Sunday, November, 15, 2026

Krystal Biotech Stock Price History

Price Date
0 Results
DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization
11/13/2026$305.68$305.23
-0.15%
$306.73$300.39109,686 shs$9.04 billion
11/12/2026$308.81$305.68
-1.01%
$309.68$304.06157,080 shs$9.06 billion
11/11/2026$306.50$308.81
+0.75%
$311.05$303.59174,762 shs$9.15 billion
11/10/2026$303.06$306.50
+1.14%
$307.48$300.86196,371 shs$9.08 billion
11/09/2026$300.88$303.06
+0.72%
$310.66$297.52281,389 shs$8.98 billion
11/06/2026$300.25$300.88
+0.21%
$305.60$297.52234,200 shs$8.92 billion
11/05/2026$310.43$300.25
-3.28%
$314.24$299.63400,889 shs$8.89 billion
11/04/2026$305.03$310.43
+1.77%
$314.75$301.80414,425 shs$9.19 billion
11/03/2026$295.90$305.03
+3.09%
$305.43$293.01603,072 shs$9.03 billion
11/02/2026$332.29$295.90
-10.95%
$317.01$281.401.20 million shs$8.76 billion
10/30/2026$324.55$332.29
+2.38%
$332.63$319.95330,046 shs$9.84 billion
10/29/2026$321.42$324.55
+0.97%
$326.98$319.43190,766 shs$9.61 billion
10/28/2026$320.58$321.42
+0.26%
$322.09$315.86199,776 shs$9.51 billion
10/27/2026$313.66$320.58
+2.21%
$321.02$311.52212,807 shs$9.49 billion
10/26/2026$311.50$313.66
+0.69%
$317.76$309.63223,642 shs$9.28 billion
10/23/2026$320.13$311.50
-2.70%
$318.91$310.56270,063 shs$9.22 billion
10/22/2026$322.17$320.13
-0.63%
$328.48$317.05245,203 shs$9.48 billion
10/21/2026$325.42$322.17
-1.00%
$327.35$319.83468,789 shs$9.54 billion
10/20/2026$320.25$325.42
+1.61%
$328.76$321.26195,436 shs$9.63 billion
10/19/2026$316.58$320.25
+1.16%
$321.65$314.22206,957 shs$9.48 billion
10/16/2026$330.00$316.58
-4.07%
$331.03$315.39226,225 shs$9.37 billion
10/15/2026$330.69$330.00
-0.21%
$338.91$328.51288,016 shs$9.77 billion

This page (NASDAQ:KRYS) was last updated on 11/13/2026 by MarketBeat.com Staff.
From Our Partners